Mail Us
Global.CustomerService@glenmarkpharma.com
Call Us
1800 266 6255
Global.CustomerService@glenmarkpharma.com
1800 266 6255
Dosage instructions for Lirafit may vary from person to person. It’s crucial to follow your healthcare provider’s recommendations. Here are some general guidelines:
Lirafit is typically injected subcutaneously (under the skin) once a day
The dosage may start low and gradually increase, depending on your response and tolerance.
You will receive detailed instructions on how to use the injectable pen. Be sure to follow these instructions carefully.
For a comprehensive guide on Lirafit’s administration, including videos, please refer to our instructional materials / Demonstration video
Some people may experience mild nausea when starting Lirafit. This usually improves with time.
In rare cases, Liraglutide may increase the risk of pancreatitis. Inform your healthcare provider if you experience severe abdominal pain.
If you develop signs of an allergic reaction (e.g., rash, swelling, difficulty breathing), seek immediate medical attention.
Inform your healthcare provider about all the medications you are taking, as interactions can occur.